PharmacoEconomics - Open

Acknowledgement to Referees

• Open Access
• Acknowledgement to Referees

The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain

• Open Access
• Original Research Article

Bérengère Macabeo, Théophile Rotrou, Aurélie Millier, Clément François, Philippe Laramée

Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure with Preserved Ejection Fraction in France, Based on the EMPEROR-Preserved Clinical Trial

• Open Access
• Original Research Article

Laurent Fauchier, Nicolas Lamblin, Jean Tardu, Lucile Bellier, Harinala Groyer, Deborah Ittah, Julien Chollet, Stephan Linden, Pierre Levy

Specialist Palliative Care and Health Care Costs at the End of Life

• Open Access
• Original Research Article

Patricia Kenny, Dan Liu, Denzil Fiebig, Jane Hall, Jared Millican, Sanchia Aranda, Kees van Gool, Philip Haywood

United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument

• Open Access
• Original Research Article

Madeleine T. King, D. A. Revicki, R. Norman, F. Müller, R.C. Viney, A. S. Pickard, D. Cella, J. W. Shaw, Neil Aaronson, John Brazier, David Cella, Daniel Costa, Peter Fayers, Peter Grimison, Monika Janda, Georg Kemmler, Madeleine T. King, Nan Luo, Helen McTaggart-Cowan, Rebecca Mercieca-Bebber, Richard Norman, Dennis Revicki, Stuart Peacock, Simon Pickard, Donna Rowen, Galina Velikova, Rosalie Viney, Deborah Street, Tracey Young, Margaret-Ann Tait

Preferences for Living Arrangements in Dementia: A Discrete Choice Experiment

• Open Access
• Original Research Article

Christian Speckemeier, Carina Abels, Klemens Höfer, Anja Niemann, Jürgen Wasem, Anke Walendzik, Silke Neusser

Developing a Natural History Model for Duchenne Muscular Dystrophy

• Open Access
• Original Research Article

Jonathan Broomfield, M. Hill, F. Chandler, M. J. Crowther, J. Godfrey, M. Guglieri, J. Hastie, J. Larkindale, J. Mumby-Croft, E. Reuben, F. Woodcock, K. R. Abrams

Cost-Effectiveness of Neoadjuvant Pembrolizumab plus Chemotherapy Followed by Adjuvant Pembrolizumab in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer in Switzerland

• Open Access
• Original Research Article

Andrea Favre-Bulle, Min Huang, Amin Haiderali, Arjun Bhadhuri

Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity

• Open Access
• Original Research Article

Laura Gómez Maldonado, Ricardo de Mora-Figueroa, Angélica López-Angarita, Paulina Maravilla-Herrera, María Merino

Exploring the Influence of Health Insurance Plans on Biosimilar Adoption Rates

• Open Access
• Original Research Article

Jeremy Costin, Morgane C. Mouslim, Mariana P. Socal, Antonio Trujillo

Early Cost-Effectiveness Analysis of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Patients with Limited Peritoneal Carcinomatosis

• Open Access
• Original Research Article

Joost G. E. Verbeek, Karen van der Sluis, Marieke A. Vollebergh, Johanna W. van Sandick, Wim H. van Harten, Valesca P. Retèl

Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH)

• Open Access
• Original Research Article

Hilary M. DuBrock, Hayley D. Germack, Marjolaine Gauthier-Loiselle, Jörg Linder, Ambika Satija, Ameur M. Manceur, Martin Cloutier, Patrick Lefebvre, Sumeet Panjabi, Robert P. Frantz